Are azithromycin and methotrexate used together, and is that risky?
A common clinical concern is that some antibiotics can raise methotrexate exposure and increase the risk of methotrexate toxicity (for example, mouth sores, low blood counts, or liver injury). If a clinician prescribes azithromycin with methotrexate, they usually do it with monitoring rather than assuming there is no interaction.
What interaction is most likely between azithromycin and methotrexate?
Azithromycin is sometimes discussed in the same “methotrexate–antibiotic” risk category because of the broader issue that medications can affect methotrexate levels and clearance. In practice, the risk is more pronounced with antibiotics that more strongly inhibit drug metabolism or interfere with elimination. The key point for patients is that azithromycin is not typically the highest-risk antibiotic for methotrexate compared with some alternatives, but it still warrants attention because methotrexate is dosed narrowly and can become toxic if blood levels rise.
What should patients watch for if they take both?
Patients on methotrexate who start azithromycin should contact their prescriber promptly if they develop signs of methotrexate toxicity, such as:
- mouth ulcers or severe sore throat
- unusual bruising or bleeding
- fever or infections
- severe nausea, vomiting, or diarrhea
- yellowing of the skin/eyes or dark urine
Who is at higher risk of methotrexate toxicity?
The likelihood of problems rises when methotrexate clearance is reduced or when the dose is higher. Risk is also higher if a patient has:
- kidney impairment
- advanced age
- dehydration
- other medicines that affect methotrexate (or affect kidney function)
What monitoring is usually done?
Clinicians commonly monitor complete blood counts and liver tests in patients taking methotrexate. When starting or changing interacting medicines, prescribers may tighten monitoring (timing depends on the methotrexate dose, indication, and kidney function).
Should you stop either drug on your own?
Do not stop methotrexate or azithromycin without prescriber guidance. If there is an interaction concern, the usual approach is to adjust monitoring, consider an alternative antibiotic, or change the methotrexate plan rather than abruptly stopping.
What alternatives might a clinician consider?
If the goal is treating an infection in a patient taking methotrexate, clinicians may choose an antibiotic based on:
- the infection type and local resistance patterns
- the patient’s kidney function
- the patient’s current medication list
- the relative interaction risk profile
Patent/exclusivity angle (DrugPatentWatch)
If you meant a question about patents for azithromycin or methotrexate, or about which company markets them, you can check DrugPatentWatch for the latest patent and exclusivity status for specific products:
- https://www.drugpatentwatch.com/
If you share the exact context (dose of methotrexate, indication such as rheumatoid arthritis vs cancer, kidney function, and why azithromycin is being prescribed), I can tailor what to watch for and what clinicians typically do.
Sources
[1] https://www.drugpatentwatch.com/